DE60222189D1 - Zwischenprodukte für die Synthese von LHRH-Antagonisten, Verfahren zu deren Herstellung und Verfahren zur Herstellung von LHRH-Antagonisten - Google Patents
Zwischenprodukte für die Synthese von LHRH-Antagonisten, Verfahren zu deren Herstellung und Verfahren zur Herstellung von LHRH-AntagonistenInfo
- Publication number
- DE60222189D1 DE60222189D1 DE60222189T DE60222189T DE60222189D1 DE 60222189 D1 DE60222189 D1 DE 60222189D1 DE 60222189 T DE60222189 T DE 60222189T DE 60222189 T DE60222189 T DE 60222189T DE 60222189 D1 DE60222189 D1 DE 60222189D1
- Authority
- DE
- Germany
- Prior art keywords
- lhrh antagonists
- boc
- 4clphe
- intermediates
- synthesis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229940124041 Luteinizing hormone releasing hormone (LHRH) antagonist Drugs 0.000 title 2
- 238000000034 method Methods 0.000 title 2
- 230000015572 biosynthetic process Effects 0.000 title 1
- 239000000543 intermediate Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- URKWHOVNPHQQTM-OAHLLOKOSA-N (2r)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-naphthalen-2-ylpropanoic acid Chemical compound C1=CC=CC2=CC(C[C@@H](NC(=O)OC(C)(C)C)C(O)=O)=CC=C21 URKWHOVNPHQQTM-OAHLLOKOSA-N 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0104463A SE0104463D0 (sv) | 2001-12-29 | 2001-12-29 | Mellanprodukter för syntes af LHRH-antagonister, sätt att framställa dem och sätt för framställning av LHRH-antagonister |
| SE0104463 | 2001-12-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60222189D1 true DE60222189D1 (de) | 2007-10-11 |
| DE60222189T2 DE60222189T2 (de) | 2008-06-19 |
Family
ID=20286557
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60222189T Expired - Lifetime DE60222189T2 (de) | 2001-12-29 | 2002-12-23 | Zwischenprodukte für die Synthese von LHRH-Antagonisten, Verfahren zu deren Herstellung und Verfahren zur Herstellung von LHRH-Antagonisten |
| DE60215544T Expired - Lifetime DE60215544T2 (de) | 2001-12-29 | 2002-12-23 | Zwischenprodukte für die synthese von lhrh-antagonisten, verfahren zu deren herstellung und verfahren zur herstellung von lhrh-antagonisten |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60215544T Expired - Lifetime DE60215544T2 (de) | 2001-12-29 | 2002-12-23 | Zwischenprodukte für die synthese von lhrh-antagonisten, verfahren zu deren herstellung und verfahren zur herstellung von lhrh-antagonisten |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US20050124788A1 (de) |
| EP (2) | EP1465917B1 (de) |
| JP (1) | JP4272529B2 (de) |
| KR (1) | KR100844520B1 (de) |
| CN (1) | CN1304417C (de) |
| AT (2) | ATE342913T1 (de) |
| AU (1) | AU2002348749B2 (de) |
| CA (1) | CA2471723C (de) |
| CY (2) | CY1107580T1 (de) |
| DE (2) | DE60222189T2 (de) |
| DK (2) | DK1465917T3 (de) |
| ES (2) | ES2296050T3 (de) |
| HK (1) | HK1075052A1 (de) |
| IL (2) | IL162788A0 (de) |
| NO (1) | NO330129B1 (de) |
| NZ (1) | NZ534245A (de) |
| PT (2) | PT1630169E (de) |
| RU (1) | RU2307125C2 (de) |
| SE (1) | SE0104463D0 (de) |
| SI (1) | SI1630169T1 (de) |
| WO (1) | WO2003055902A1 (de) |
| ZA (1) | ZA200405136B (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4407322B2 (ja) | 2004-03-09 | 2010-02-03 | 味の素株式会社 | ペプチドの製造方法 |
| CN101037472B (zh) * | 2006-03-14 | 2013-03-27 | 中国人民解放军军事医学科学院毒物药物研究所 | 具有低组胺释放作用的促黄体生成素释放激素拮抗剂 |
| JOP20090061B1 (ar) | 2008-02-11 | 2021-08-17 | Ferring Int Center Sa | طريقة معالجة سرطان البروستاتا بمضادات الهرمونات التناسلية GnRH |
| US9260480B2 (en) | 2010-10-27 | 2016-02-16 | Ferring B.V. | Process for the manufacture of Degarelix and its intermediates |
| EP2447276A1 (de) * | 2010-10-27 | 2012-05-02 | Ferring B.V. | Verfahren zur Herstellung von Degarelix und seinen Zwischenprodukten |
| EP2854831B1 (de) | 2012-06-01 | 2024-07-10 | Ferring B.V. | Herstellung von degarelix |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4098777A (en) * | 1977-03-14 | 1978-07-04 | Merck & Co., Inc. | Process for the preparation of pyroglutamyl-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn |
| US5225598A (en) * | 1990-03-30 | 1993-07-06 | Union Carbide Chemicals & Plastics Technology Corporation | Selective production of linear pentaethylenehexamine and hydroxyethyldiethylenetriamine |
| EP0540626A1 (de) * | 1990-07-24 | 1993-05-12 | Eastman Chemical Company | Verfahren zur synthese von peptiden |
| US5710246A (en) * | 1996-03-19 | 1998-01-20 | Abbott Laboratories | Process for intermediates for the synthesis of LHRH antagonists |
| US6235734B1 (en) * | 1996-10-30 | 2001-05-22 | Pfizer Inc | Pyridone-fused azabicyclic- or cytisine derivatives, their preparation and their use in addiction therapy |
| US5968895A (en) * | 1996-12-11 | 1999-10-19 | Praecis Pharmaceuticals, Inc. | Pharmaceutical formulations for sustained drug delivery |
| DE19941248A1 (de) | 1998-09-01 | 2000-03-02 | Asta Medica Ag | Peptide mit N-substituierten Glycingruppen sowie diese enthaltende Arzneimittel zur Behandlung hormonabhängiger Tumore |
-
2001
- 2001-12-29 SE SE0104463A patent/SE0104463D0/xx unknown
-
2002
- 2002-12-23 DE DE60222189T patent/DE60222189T2/de not_active Expired - Lifetime
- 2002-12-23 DK DK02781699T patent/DK1465917T3/da active
- 2002-12-23 CA CA2471723A patent/CA2471723C/en not_active Expired - Fee Related
- 2002-12-23 RU RU2004119964/04A patent/RU2307125C2/ru not_active IP Right Cessation
- 2002-12-23 CN CNB028283813A patent/CN1304417C/zh not_active Expired - Fee Related
- 2002-12-23 NZ NZ534245A patent/NZ534245A/en not_active IP Right Cessation
- 2002-12-23 EP EP02781699A patent/EP1465917B1/de not_active Expired - Lifetime
- 2002-12-23 EP EP05025717A patent/EP1630169B1/de not_active Expired - Lifetime
- 2002-12-23 JP JP2003556432A patent/JP4272529B2/ja not_active Expired - Fee Related
- 2002-12-23 DE DE60215544T patent/DE60215544T2/de not_active Expired - Lifetime
- 2002-12-23 IL IL16278802A patent/IL162788A0/xx unknown
- 2002-12-23 DK DK05025717T patent/DK1630169T3/da active
- 2002-12-23 SI SI200230642T patent/SI1630169T1/sl unknown
- 2002-12-23 AT AT02781699T patent/ATE342913T1/de active
- 2002-12-23 PT PT05025717T patent/PT1630169E/pt unknown
- 2002-12-23 ES ES05025717T patent/ES2296050T3/es not_active Expired - Lifetime
- 2002-12-23 AU AU2002348749A patent/AU2002348749B2/en not_active Ceased
- 2002-12-23 ES ES02781699T patent/ES2275012T3/es not_active Expired - Lifetime
- 2002-12-23 PT PT02781699T patent/PT1465917E/pt unknown
- 2002-12-23 WO PCT/IB2002/005583 patent/WO2003055902A1/en active Search and Examination
- 2002-12-23 AT AT05025717T patent/ATE371666T1/de active
- 2002-12-23 KR KR1020047010267A patent/KR100844520B1/ko not_active IP Right Cessation
- 2002-12-23 US US10/500,047 patent/US20050124788A1/en not_active Abandoned
-
2004
- 2004-06-28 ZA ZA2004/05136A patent/ZA200405136B/en unknown
- 2004-06-29 IL IL162788A patent/IL162788A/en not_active IP Right Cessation
- 2004-07-16 NO NO20043047A patent/NO330129B1/no not_active IP Right Cessation
-
2005
- 2005-08-23 HK HK05107366A patent/HK1075052A1/xx not_active IP Right Cessation
-
2007
- 2007-01-18 CY CY20071100070T patent/CY1107580T1/el unknown
- 2007-11-27 CY CY20071101513T patent/CY1107025T1/el unknown
-
2008
- 2008-08-12 US US12/189,925 patent/US8173770B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60202958D1 (de) | Stabiles polymorph von flibanserin, industrielles verfahren zu dessen herstellung und dessen verwendung zur herstellung von medikamenten | |
| ATE407127T1 (de) | Verfahren zur herstellung von beraprost und dessen salzen | |
| HK1075052A1 (en) | Intermediates for lhrh antagonist synthesis, proc ess for their production, and process for lhrh antagonist production | |
| ATE457972T1 (de) | Verfahren zur herstellung von 7-amino-syn-3,5- dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung | |
| NO20053176L (no) | Fremgangsmate for fremstilling av tolperisonsalter. | |
| MXPA03006996A (es) | Diamidas del acido ftalico, procedimiento para su obtencion y su uso como agentes pesticidas. | |
| ATE438653T1 (de) | Verfahren zur herstellung von diphosphinverbindungen und zwischenprodukte für das verfahren | |
| ATE314377T1 (de) | Verfahren zur herstellung von cephalosporin- verbindungen und zwischenprodukte für die synthese dieser verbindungen | |
| ATE223414T1 (de) | Prozess zur herstellung von zwischebprodukten für imidazodeazepinen | |
| ATE280769T1 (de) | Verfahren zur herstellung von vitronectin- rezeptorantagonisten | |
| ATE300534T1 (de) | Verfahren und zwischenverbindungen zur herstellung von imidazopyridinen | |
| DE602004029079D1 (de) | Verfahren zur herstellung einer epoxytriazolverbindung und zwischenprodukt dafür | |
| DE60200406D1 (de) | Verfahren zur Herstellung von Midodrin | |
| DE50309092D1 (de) | Verfahren zur herstellung von palladium(0)-haltigen verbindungen | |
| DE60229261D1 (de) | Verfahren zur herstellung von säureanhydrid | |
| ATE330612T1 (de) | Verfahren zur herstellung von benazeprilhydrochloride | |
| ATE508109T1 (de) | Verfahren zur herstellung von optisch aktiven sulfonamiden und zwischenprodukte zur deren synthese | |
| ATE250581T1 (de) | Verfahren zur herstellung von 3-cyanopyridin aus 2-methyl-1,5-pentandiamin | |
| DE60323308D1 (de) | Verfahren zur Herstellung von n-alkoxycarbonyl-piperidin Derivaten sowie Zwischenverbindungen dafür | |
| DE60327765D1 (de) | Verfahren zur herstellung von n-(2,6-dimethylphenyl)-2-piperazin-1-ylacetamid | |
| ATE404540T1 (de) | Verfahren zur herstellung von 1-substituierten 5- chlor-4methylpyrazolen | |
| ATE297478T1 (de) | Verfahren zur herstellung von orthocarbonsäuretrialkylestern | |
| ATE378324T1 (de) | Verfahren zur herstellung von tetrahydropyran-4- ol, zwischenprodukte daf r und verfahren zu dessen herstellung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |